Infectious Disease Rapid Diagnostic Testing Market is Expected to top US$ 3.56 Bn with CAGR of around 12.2% by 2027

The rising incidence of infectious diseases & shift in focus from centralized laboratories to decentralized point-of-care testing is driving the market demand.

VANCOUVER, BC, CANADA, March 26, 2022 /EINPresswire.com/ — The global Infectious Disease Rapid Diagnostic Testing Market is forecasted to be worth USD 3.56 Billion by 2027, according to a current analysis by Emergen Research. The rising cases of infectious disease all over the globe and the need for the immediate diagnosis will propel market growth. The evolving pathogens and rise in the occurrence of hospital-acquired infections (HAIs) are creating a need for a quick diagnosis of the diseases to stop the spread. Governments all over the world are investing in rapid diagnostic testing kits to increase their rate of testing and prevent any sort of epidemic.

Get a sample of the report @

The advancement in technology has also encouraged the infectious disease rapid diagnostic testing market growth. Investment in research and development has helped in the development of effective diagnostic testing kits, which have helped in the advancement in the market product. However, the lack of proper reimbursement rates may result in lower access for patients to testing, which hinders market growth.

There is a surge in infectious diseases such as hepatitis, malaria, tuberculosis, influenza, and HIV-AIDS. The rise in the SARS-Cov-19 virus has led to the massive demand for infectious disease rapid diagnostic testing products. All the nations are focusing on flattening the curve of the community transmission, which is propelling the demand for the market. Another factor driving the demand for the product is the scale-up of manufacturing capabilities by the market players. Industry players are expanding to fulfill the growing demand for the product in the current scenario.

Prominent Players Analyzed in the Report:
Abbott Laboratories, Danaher Corporation, BGI Group, DiaSorin S.p.A, F. Hoffmann-La Roche Ltd., Luminex Corporation, bioMérieux S.A., Hologic, Inc., Thermo Fisher Scientific Inc., and Becton, Dickinson, and Company, among others.

Some Key Highlights from the Report:
Bio-Rad Laboratories, in February 2020, acquired Exact Diagnostics of Fort Worth. The acquisition helped the company gain accessibility to a catalog of molecular quality control products in virology, microbiology, respiratory, transplant vector-borne, and sexually transmitted infections.
North America is expected to witness several growth opportunities resulting in an increase in the level of awareness among consumers. The presence of a large number of educational institutes, corporate buildings, hospitals, and also a rise in the self-hygiene among people will significantly impact the industry’s growth.
The lateral flow assay is among the most popular diagnostic tool that meets the requirement of colorimetric assays. It is an ideal diagnostic test, including features such as easy operation, less time consumption, durable stability, and low cost for the POC test.

To know more about the report, visit @

Emergen Research has segmented the global Infectious Disease Rapid Diagnostic Testing Market on the basis of product type, deployment mode, application, end-users, and region:

Product Outlook (Revenue, USD Billion; 2017-2027)
Platforms
Assays

Technology Outlook (Revenue, USD Billion; 2017-2027)
Isothermal Nucleic Acid Amplification Technology (INAAT)
Enzyme Immunoassay (EIA)
Real-Time PCR (q-PCR)
Lateral Flow Immunoassay (LFIA)
Others

Disease Outlook (Revenue, USD Billion; 2017-2027)
Bacterial Infection
CT/NG
HAIs
Tuberculosis
Others
Viral Infection
Hepatitis
Influenza Virus
HPV
HIV-AIDS
Others
Others Infections

End-User Outlook (Revenue, USD Billion; 2017-2027)
Clinics
Hospital
Diagnostic Center
Others

Request a discount on the report @

Regional Outlook (Revenue, USD Billion; 2017-2027)
North America
U.S.
Canada
Europe
Germany
UK
France
BENELUX
Rest of Europe
Asia Pacific
China
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
MEA
Saudi Arabia
UAE
Rest of MEA

Request customization of the report @

Overview of the Infectious Disease Rapid Diagnostic Testing Market Report:
Introduction, Product Scope, Market Overview, and Opportunities
Analysis of the Manufacturers with sales, revenue, and price analysis
Comprehensive analysis of the competitive landscape
Extensive profiling of the key competitors along with their business strategies and market size
Regional analysis of the market along with sales, revenue, market share, and global position
Country-wise analysis of the market along with types, applications, and manufacturing
Strategic recommendations to established players as well as new entrants
In-depth analysis of the risks, restraints, and limitations in the Infectious Disease Rapid Diagnostic Testing industry

Thank you for reading our report. Please connect with us to know more about the report or the customization of the report. Our team will ensure the report is best suited to meet your requirements.

Table of Content
Chapter 1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Market Estimation Technique

Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027

Chapter 3. Key Insights

Chapter 4. Infectious Disease Rapid Diagnostic Testing Market Segmentation & Impact Analysis
4.1. Infectious Disease Rapid Diagnostic Testing Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
4.2.2.1. Increasing prevalence of infectious diseases
4.2.2.2. Growth in funding for research on infectious disease diagnostics
4.2.3. Market restraints analysis
4.2.3.1. Inadequate reimbursements
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter’s Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis

Chapter 5. Infectious Disease Rapid Diagnostic Testing Market By Product Insights & Trends Revenue (USD Million)

Continued…

Browse More Related Reports:

Newborn Screening Market :

Regenerative Medicine Market:

Interoperability Solutions in Healthcare Market:

Radiation Dose Management Market:

Deep Brain Stimulation (DBS) Systems Market:

Metastatic urothelial carcinoma Market :

About Emergen Research:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Eric Lee
Emergen Research
+91 90210 91709
[email protected]
Visit us on social media:
Facebook
Twitter
LinkedIn